Enzon Pharmaceuticals (ENZN) Short Interest Ratio & Short Volume $0.19 +0.06 (+44.87%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Enzon Pharmaceuticals Short Interest DataEnzon Pharmaceuticals (ENZN) has a short interest of 1,600 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 32,288 shares to cover all short positions.Current Short Interest1,600 sharesPrevious Short Interest1,600 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$128.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares74,220,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume683,174 sharesAverage Trading Volume32,288 sharesToday's Volume Vs. Average2,116% Short Selling Enzon Pharmaceuticals? Sign up to receive the latest short interest report for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENZN Short Interest Over TimeENZN Days to Cover Over TimeENZN Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Enzon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,600 shares $128.00 No ChangeN/A0 $0.08 11/15/20241,600 shares $131.20 -40.7%N/A0.1 $0.08 10/31/20242,700 shares $243.00 +68.8%N/A0 $0.09 10/15/20241,600 shares $187.52 No ChangeN/A0.1 $0.12 9/30/20241,600 shares $224.00 -33.3%N/A0.1 $0.14 9/15/20242,400 shares $302.54 +50.0%N/A0 $0.13 Get the Latest News and Ratings for ENZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/31/20241,600 shares $232.96 No ChangeN/A0.1 $0.15 8/15/20241,600 shares $256.32 -64.4%N/A0 $0.16 7/31/20244,500 shares $675.00 -61.2%N/A0.3 $0.15 7/15/202411,600 shares $1,787.56 -37.0%N/A0.8 $0.15 6/30/202418,400 shares $3,312.00 -3.7%N/A0.7 $0.18 6/15/202419,100 shares $2,677.82 -28.5%N/A0.1 $0.14 5/31/202426,700 shares $3,471.00 +1,568.8%N/A0.2 $0.13 5/15/20241,600 shares $144.00 No ChangeN/A0 $0.09 4/30/20241,600 shares $133.52 -87.6%N/A1.5 $0.08 4/15/202412,900 shares $964.92 +239.5%N/A0.6 $0.07 3/31/20243,800 shares $359.10 +137.5%N/A0.1 $0.09 3/15/20241,600 shares $132.48 -73.3%N/A0 $0.08 2/29/20246,000 shares $393.00 +275.0%N/A0.3 $0.07 2/15/20241,600 shares $144.00 -20.0%N/A0.1 $0.09 1/15/20241,600 shares $142.08 No ChangeN/A0.1 $0.09 12/31/20231,600 shares $149.68 -42.9%N/A0 $0.09 12/15/20232,800 shares $288.40 -58.2%N/A0.1 $0.10 11/30/20236,700 shares $703.50 +318.8%N/A0.1 $0.11 11/15/20231,600 shares $224.00 No ChangeN/A0.3 $0.14 10/31/20231,600 shares $240.00 No ChangeN/A0.1 $0.15 10/15/20231,600 shares $221.12 No ChangeN/A0.1 $0.14 9/30/20231,600 shares $234.68 -76.8%N/A0.2 $0.15 9/15/20236,900 shares $938.40 -42.0%N/A0.3 $0.14 8/31/202311,900 shares $1,844.50 +643.8%N/A0.7 $0.16 8/15/20231,600 shares $240.00 -27.3%N/A0.1 $0.15 7/31/20232,200 shares $440.00 No ChangeN/A0.3 $0.20 7/15/20232,200 shares $440.00 -57.7%N/A0.2 $0.20 6/30/20235,200 shares $1,040.00 +136.4%N/A0.1 $0.20 6/15/20232,200 shares $310.20 -33.3%N/A0.1 $0.14 5/31/20233,300 shares $445.50 +106.3%N/A0.1 $0.14 5/15/20231,600 shares $251.20 No ChangeN/A0 $0.16 4/30/20231,600 shares $328.00 -33.3%N/A0.2 $0.21 4/15/20232,400 shares $494.40 -7.7%N/A0.1 $0.21 3/31/20232,600 shares $676.00 -75.5%N/A0.1 $0.26I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 3/15/202310,600 shares $2,647.88 +523.5%N/A0.5 $0.25 2/28/20231,700 shares $433.50 -81.1%N/A0 $0.26 2/15/20239,000 shares $2,475.00 +350.0%N/A0.7 $0.28 1/31/20232,000 shares $530.00 -85.2%N/A0.2 $0.27 1/15/202313,500 shares $3,510.00 -27.0%N/A0.2 $0.26 12/30/202218,500 shares $4,563.03 No ChangeN/A0.4 $0.25 12/15/202218,500 shares $4,838.86 +1,056.3%N/A0.5 $0.26 11/30/20221,600 shares $439.68 -92.1%N/A0.1 $0.27 11/15/202220,200 shares $5,454.00 +910.0%N/A0.3 $0.27 10/31/20222,000 shares $580.00 -73.3%N/A0 $0.29 10/15/20227,500 shares $2,100.00 -7.4%N/A0.5 $0.28 9/30/20228,100 shares $2,292.30 +268.2%N/A0.1 $0.28 9/15/20222,200 shares $679.36 -66.2%N/A0.1 $0.31 8/31/20226,500 shares $1,768.00 +140.7%N/A0 $0.27 8/15/20222,700 shares $1,077.30 -54.2%N/A0 $0.40 7/31/20225,900 shares $1,976.50 +247.1%N/A0.2 $0.34 7/15/20221,700 shares $501.50 -95.2%N/A0 $0.30 6/30/202235,200 shares $10,736.00 +2,100.0%N/A0.3 $0.31 6/15/20221,600 shares $448.00 -5.9%N/A0 $0.28 5/31/20221,700 shares $518.50 -56.4%N/A0.1 $0.31 5/15/20223,900 shares $1,150.50 -81.7%N/A0.1 $0.30 4/30/202221,300 shares $6,713.76 +191.8%N/A0.2 $0.32 4/15/20227,300 shares $2,568.14 +265.0%N/A0.1 $0.35 3/31/20222,000 shares $604.80 -35.5%N/A0.1 $0.30 3/15/20223,100 shares $931.55 +24.0%N/A0.1 $0.30 2/28/20222,500 shares $800.00 -30.6%N/A0.1 $0.32 2/15/20223,600 shares $1,311.12 +125.0%N/A0 $0.36 1/31/20221,600 shares $656.00 -81.4%N/A0 $0.41 1/15/20228,600 shares $3,053.00 +437.5%N/A0.2 $0.36 12/31/20211,600 shares $548.00 No ChangeN/A0 $0.34 12/15/20211,600 shares $528.00 -76.5%N/A0 $0.33 11/30/20216,800 shares $2,512.60 -53.7%N/A0 $0.37 11/15/202114,700 shares $5,143.53 +818.8%N/A0.1 $0.35 10/29/20211,600 shares $511.52 -40.7%N/A0 $0.32 10/15/20212,700 shares $915.30 -30.8%N/A0.1 $0.34 9/30/20213,900 shares $1,471.86 -48.7%N/A0 $0.38 9/15/20217,600 shares $2,750.44 -12.6%N/A0.1 $0.36 8/31/20218,700 shares $2,872.74 +8.8%N/A0.1 $0.33 8/13/20218,000 shares $3,280.00 -16.7%N/A0 $0.41 7/30/20219,600 shares $5,181.12 +15.7%N/A0.1 $0.54 7/15/20218,300 shares $5,436.50 +196.4%N/A0.1 $0.66 6/30/20212,800 shares $1,848.00 -60.0%N/A0 $0.66 6/15/20217,000 shares $5,173.00 -7.9%N/A0.1 $0.74 5/28/20217,600 shares $4,405.72 +31.0%N/A0.1 $0.58 5/14/20215,800 shares $3,221.90 -34.8%N/A0.1 $0.56 4/30/20218,900 shares $5,340.00 +178.1%N/A0.1 $0.60 4/15/20213,200 shares $2,300.80 -76.8%N/A0 $0.72 3/31/202113,800 shares $10,555.62 +762.5%N/A0.1 $0.76 3/15/20211,600 shares $1,008.00 -76.5%N/A0 $0.63 2/26/20216,800 shares $4,178.87 +161.5%N/A0 $0.61I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/12/20212,600 shares $1,567.28 -94.1%N/A0 $0.60 1/29/202144,400 shares $19,536.00 +21.6%N/A0.1 $0.44 1/15/202143,700 shares $13,765.50 +241.4%N/A0.1 $0.32 12/31/202024,500 shares $6,588.05 -43.9%N/A0.1 $0.27 12/15/202043,700 shares $10,925.00 +241.4%N/A0.1 $0.25 11/30/202012,800 shares $2,329.60 -36.6%N/A0.1 $0.18 11/15/202020,200 shares $3,050.20 +5.8%N/A0.2 $0.15 10/30/202019,100 shares $2,779.05 +135.8%N/A0.2 $0.15 10/15/20208,100 shares $1,297.62 +88.4%N/A0 $0.16 9/30/20204,300 shares $796.36 -62.0%N/A0.1 $0.19 9/15/202011,300 shares $1,989.93 -29.8%N/A0.1 $0.18 8/31/202016,100 shares $3,052.56 -53.9%N/A0.1 $0.19 8/14/202034,900 shares $7,503.50 +122.3%N/A0.1 $0.22 7/31/202015,700 shares $3,140.00 -38.2%N/A0.3 $0.20 7/15/202025,400 shares $4,140.20 +103.2%N/A0.8 $0.16 6/30/202012,500 shares $2,180.00 -30.2%N/A0.8 $0.17 6/15/202017,900 shares $3,141.45 -67.7%N/A0.5 $0.18 5/29/202055,400 shares $9,911.06 +32.2%N/A3 $0.18 5/15/202041,900 shares $7,521.05 -31.7%N/A0.9 $0.18 4/30/202061,300 shares $11,003.35 +656.8%N/A0.8 $0.18 4/15/20208,100 shares $1,263.60 -80.9%N/A0 $0.16 3/31/202042,500 shares $6,800.00 +962.5%N/A0.3 $0.16 3/13/20204,000 shares $640.00 +66.7%N/A0.1 $0.16 2/28/20202,400 shares $444.00 -40.0%N/A0 $0.19 2/14/20204,000 shares $680.00 -9.1%N/A0.1 $0.17 1/31/20204,400 shares $924.00 No ChangeN/A0.2 $0.21 1/15/20204,400 shares $924.00 -79.9%N/A0.2 $0.21 12/31/201921,900 shares $4,599.00 +1,268.8%N/A0.3 $0.21 ENZN Short Interest - Frequently Asked Questions What is Enzon Pharmaceuticals' current short interest? Short interest is the volume of Enzon Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 1,600 shares of ENZN short. Learn More on Enzon Pharmaceuticals' current short interest. How does Enzon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biotechnology" compare to Enzon Pharmaceuticals: SAB Biotherapeutics, Inc. (1.32%), Curis, Inc. (0.99%), Bolt Biotherapeutics, Inc. (0.47%), Molecular Templates, Inc. (3.88%), Amgen Inc. (2.08%), Vertex Pharmaceuticals Incorporated (1.43%), Gilead Sciences, Inc. (1.89%), Regeneron Pharmaceuticals, Inc. (1.64%), Alnylam Pharmaceuticals, Inc. (2.63%), Biogen Inc. (1.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Enzon Pharmaceuticals stock? Short selling ENZN is an investing strategy that aims to generate trading profit from Enzon Pharmaceuticals as its price is falling. ENZN shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enzon Pharmaceuticals? A short squeeze for Enzon Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZN, which in turn drives the price of the stock up even further. How often is Enzon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZN, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies SABS Short Squeeze CRIS Short Squeeze BOLT Short Squeeze MTEM Short Squeeze AFFY Short Squeeze AMGN Short Squeeze VRTX Short Squeeze GILD Short Squeeze REGN Short Squeeze ALNY Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ENZN) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZN Stock Alerts